Large numbers of women undergo antidepressant treatment during pregnancy; however, long-term consequences for their offspring remain largely unknown. Rodents exposed to serotonin transporter (SERT)-inhibiting antidepressants during development show changes in adult emotion-like behavior. These changes have been equated with behavioral alterations arising from genetic reductions in SERT. Both models are highly relevant to humans yet they vary in their time frames of SERT disruption. We find that anxiety-related behavior and, importantly, underlying serotonin neurotransmission diverge between the two models. In mice, constitutive loss of SERT causes life-long increases in anxiety-related behavior and hyperserotonemia. Conversely, early exposure to the antidepressant escitalopram (ESC; Lexapro) results in decreased anxiety-related behavior beginning in adolescence, which is associated with adult serotonin system hypofunction in the ventral hippocampus. Adult behavioral changes resulting from early fluoxetine (Prozac) exposure were different from those of ESC and, although somewhat similar to SERT deficiency, were not associated with changes in hippocampal serotonin transmission in late adulthood. These findings reveal dissimilarities in adult behavior and neurotransmission arising from developmental exposure to different widely prescribed antidepressants that are not recapitulated by genetic SERT insufficiency. Moreover, they support a pivotal role for serotonergic modulation of anxiety-related behavior.
INTRODUCTION
In the United States, 15% of pregnant women suffer from anxiety disorders and depression (Cahir et al, 2007; Oberlander et al, 2006) , and many are prescribed antidepressants. As a result, 5% of babies born in the United States (200 000/year) are exposed via maternal transmission to selective-serotonin reuptake inhibitors (SSRIs), the most widely prescribed class of antidepressants. Withdrawal effects (Nordeng et al, 2001 ) and delayed motor coordination (Casper et al, 2003) have been observed in infants exposed to SSRIs in utero. Internalizing behaviors, ie, isolation, somatic complaints, and anxious/depressed behaviors, may also be more prevalent in these children (Oberlander et al, 2009 ). However, not all studies report behavioral changes in the offspring of mothers taking SSRIs during pregnancy (Casper et al, 2003; Misri et al, 2006) . Furthermore, although the first SSRI to be prescribed in the United States, fluoxetine, has now been available for 25 years (Wenthur et al, 2014) , no studies have examined the long-term behavioral consequences for adult offspring of mothers who took this drug during pregnancy.
Although poorly studied in humans, long-term behavioral effects associated with developmental antidepressant exposure in rodents have been widely studied (Oberlander et al, 2009; Vogel et al, 1990) . Administration of serotonin transporter (SERT)-inhibiting antidepressants to mice or rats during the first 3 weeks after birth alters a range of adult behaviors, including sexual activity, rapid eye movement sleep, exploratory behavior, behavioral despair, and learning. This critical postnatal period of vulnerability in rodents corresponds to the third trimester of pregnancy through the first year of life in humans in terms of brain development (Clancy et al, 2007; Workman et al, 2013) .
In addition to inhibition by antidepressants, SERT function is potentially modified by a number of commonly occurring human SERT gene (SLC6A4) polymorphisms (Murphy et al, 2013; Murphy and Moya, 2011) . Reductions in SERT associated with low-expressing SLC6A4 alleles have most often been linked to heightened anxiety-related personality traits (eg, neuroticism), stress-sensitivity, and increased susceptibility to mood disorders (Caspi et al, 2010; Mitchell et al, 2011) . Rodents do not natively express Sert gene polymorphisms analogous to those in humans. Nevertheless, mice and rats with constitutive differences in SERT expression have been engineered (Bengel et al, 1998; Homberg et al, 2007; Jennings et al, 2006) . SERT expression, which is decreased by 450% in human lymphoblasts with low-expressing 5-HTTLPR and rs25531 allelic combinations (Hu et al, 2006) is modeled here by mice lacking one functional Sert allele (SERT þ / À mice). Like humans, the most consistent behavioral phenotype associated with SERT deficiency or overexpression in rodents involves elevated or reduced anxiety-like behavior, respectively (Holmes et al, 2003a; Murphy and Lesch, 2008b; Olivier et al, 2008) . SERTdeficient mice also show enhanced stress sensitivity (Li et al, 1999; Tjurmina et al, 2002) .
In previous studies, altered locomotor, exploratory, and in some cases, depression-like behaviors in rodents following postnatal SSRI exposure have been equated to the effects of constitutive SERT deficiency (Ansorge et al, 2008; Ansorge et al, 2004; Yu et al, 2014) . Interpretations of behavioral similarities led to the idea that the effects of SLC6A4 gene polymorphisms might be limited to sensitive developmental periods (Homberg et al, 2010; Sibille and Lewis, 2006) . Although attractive, the notion that brief early-life SERT inhibition recapitulates life-long constitutive SERT deficiency seems unlikely, because it neglects to account for the ongoing effects of genetic reductions in SERT on serotonin neurotransmission Yang et al, 2013) . We alternately theorized that these two modes of SERT disruption lead to divergent neurochemical endophenotypes (hyperserotonergic vs hyposerotonergic; Figure 1 ) that produce opposing changes in anxiety-related behavior. Testing this hypothesis is important for delineating the roles of SERT and serotonin neurotransmission in the development and maintenance of anxiety-related behavioral states and understanding the potential influence of developmental antidepressant exposure on adult behavior and susceptibility to neuropsychiatric disorders.
MATERIALS AND METHODS

Animals and Treatments
Mice lacking one functional SERT allele (SERT þ / À mice) on a CD-1 Â 129SvEv background were bred to produce SERT þ / þ , SERT þ / À , and SERT À / À mice. For postnatal antidepressant exposure, SERT þ / þ mice from this line were bred for one generation to produce wild-type animals on the same genetic background as SERT-deficient mice. SERT-deficient mice on this background have been intercrossed continuously since 1997 to produce a congenic line with robust breeding characteristics and adult anxietylike behavior similar to SERT-deficient mice on a C57BL/6J background (Bengel et al, 1998; Mathews et al, 2004; Perez and Andrews, 2005) . All mice were maintained on a 12-h light/dark cycle (lights off at 1500 hours) with ad libitum food and water. Procedures involving animals were approved by local Animal Care and Use Committees and were in accordance with the National Institutes of Health Animal Care and Use Guidelines.
For the periadolescent study, 163 mice in groups of 8-16 mice per sex and drug treatment were studied. A total of 420 mice were studied with respect to the adult time points.
Here, groups contained 13-28 mice per sex, age, and genotype or drug treatment (Supplementary Table S1 ). Wild-type neonates used for postnatal antidepressant exposure were weighed daily beginning on P5 and ending on P21 to determine dosing solution volumes. This postnatal time frame has been identified as a critical developmental window during which exposure to drugs that inhibit SERT generate lasting changes in emotion-related behavior in rodents (Ansorge et al, 2008; Ansorge et al, 2004; Karpova et al, 2009; Maciag et al, 2006; Mirmiran et al, 1981; Popa et al, 2008; Vogel et al, 1990) . Mice were injected subcutaneously (sc) with saline, fluoxetine (FLX; 10 mg/kg/ day) or ESC (10 mg/kg/day). Drug doses were calculated for the free bases. Rationales for these doses and administration time frames were based on previous studies demonstrating the persistent effects of similar dose regimens on physiology and behavior after early postnatal exposure in mice (Ansorge et al, 2008; Popa et al, 2008) . For the periadolescent portion of the study, ESC-treated mice were directly compared with saline-injected controls, as well as uninjected, unhandled mice.
Drugs were dissolved in sterile, endotoxin-free saline at 1 mg/ml. Injection volumes were 10 ml/kg. During brief, 5-min periods of maternal separation for injections, nests containing all pups were transferred to containers of warmed, dry rice to maintain pup body temperatures. Following weighing and injections, nests were immediately returned to their mothers in the home cages. Saline, FLX, and ESC treatment were randomized across pups in each litter. Injections started 1 h before the onset of the dark cycle. Offspring of SERT þ / À parents were not handled or injected, because mice deficient in SERT display heightened sensitivity to stressful stimuli, including saline injection (Li et al, 1999; Tjurmina et al, 2002) . Moreover, the overwhelming majority of previous studies on emotionrelated behavior in mice with genetically manipulated Sert levels have not involved animals subjected to postnatal injection paradigms.
Postnatal antidepressant-treated and SERT-deficient mice were tested on measures of anxiety-, depression-, and activity-related behavior beginning at 2, 3, or 10 months of age. A single investigator (SCA) carried out all drug treatments, handling, and behavior testing. Behavior testing took place during the dark phase under dim light simulating ethologically relevant conditions where rodents are most active. Behavior tests were conducted 3 days apart in the order listed below such that swim or injection stress did not influence behavior in the elevated plus maze. Behavior variables were scored in either an automated fashion or by trained observers who were blind to group assignment.
Elevated Plus Maze
The elevated plus maze was used to assess anxiety-related behavior (Walf and Frye, 2007) . A single maze was used throughout the study having two opposing open arms (30 cm length Â 5 cm width) with a 0.5-cm lip around the edges of the open arms to prevent animals from falling (Lapiz-Bluhm et al, 2008) . The maze also had two opposing closed arms (30 cm length Â 5 cm width Â 15 cm height) and a center platform (5 cm Â 5 cm) and was raised 38.5 cm from the floor. The walls of the closed arms were constructed of clear Plexiglas to ensure even light levels across all arms. The floor of the maze was constructed of a continuous piece of opaque Plexiglas. Mice were placed on the center platform facing a closed arm and allowed to explore the maze freely for 5 min. The maze was cleaned with 70% ethanol and dried between mice. Behavior was 
Open Field Test
Locomotor activity in an open field was assessed using a three-point digital video tracking system and Viewer 2 software (BIOBSERVE GmbH, Bonn, Germany). Open field arenas were 50 cm Â 50 cm Â 40 cm height. The center area Figure 1 Different time frames of serotonin transporter (SERT) disruption and effects on serotonin transmission and anxiety-related behavior. Synthesis of brain serotonin begins during early embryonic development in mice (embryonic (E) day 12.5) and is preceded by the expression of transcription factors, ie, Pet-1 ETS, Lmx1b, and Gata3, necessary for serotonergic phenotype determination (1 and 2). Serotonin transporter expression is observed as early as E12.5 in brain stem serotonin neurons and also occurs briefly in nonserotonergic neurons (BE13 through postnatal (P) day 21), predominately in thalamic glutamatergic neurons projecting to cortical sensory processing areas (3). Serotonin transporter expression and function continue to increase throughout adulthood (4). We hypothesized that SERT inhibition limited to early postnatal development (P5-P21) via exposure to selective serotonin reuptake inhibitors (SSRIs) in mice would produce changes in serotonin system function and behavior different from those arising from constitutive SERT deficiency, which alters SERT function throughout life. We discovered that postnatal administration of the antidepressant escitalopram (ESC) but not fluoxetine results in a hyposerotonergic state during adulthood associated with reduced anxiety-related behavior in the elevated plus maze (EPM). This directly contrasts with the hyperserotonergic state (increased extracellular serotonin levels) and increased anxiety-like behavior in mice with lifelong reductions in Sert gene expression. Hyposerotonemia is accompanied by 5-HT 1A autoreceptor hypersensitivity in mice exposed to postnatal ESC, while genetic SERT deficiency causes desensitization of 5-HT 1A autoreceptors.
was defined by a 22 cm Â 22 cm central square. Animals were considered to be in the center after the midpoint of the body entered the center area. Mice were placed in a corner of the open field and allowed to freely explore for 60 min. Only the data for the first 30 min were used in the analyses. Total distance traveled (cm) and the ratio of center distance to total distance was measured. Additionally, time spent exploring the center region was analyzed. Testing environments were thoroughly cleaned with 70% ethanol and allowed to dry between mice.
Forced Swim Test
This test was carried out as previously described with minor modifications (Porsolt et al, 1977; Shen et al, 2010) . Briefly, each mouse was placed in a clear glass cylinder (27 cm high Â 13 cm diameter) containing room temperature water (22±2 1C) at a depth of 15 cm. Behavior was videotaped during 6-min swim sessions. Afterwards, mice were transferred to a warm environment while their fur dried before being returned to their home cages. Mice were retested under the same conditions 24 h later to assess the effects of repeated swim stress (Borsini et al, 1989; Porsolt et al, 1977) , which is thought to alter depression-like behavior in SERT-deficient mice on a C57BL/6J background (Carroll et al, 2007) . Cylinders were cleaned with 70% ethanol and refilled with fresh water between mice. Data were collected and analyzed in 1-min bins using FST High Throughput Forced Swim Test Analysis software (BIOB-SERVE GmbH). Time spent immobile during the last 4 min of each 6 min trial was summed (Porsolt et al, 2001 ).
Presynaptic Serotonin 1A (5-HT 1A ) Receptor Function
We investigated 5-HT 1A autoreceptors because this receptor subtype is critical for controlling serotonergic neurotransmission (Richer et al, 2002) and is implicated in antidepressant and anti-anxiety responses (Altieri et al, 2012; Altieri et al, 2013; Hjorth and Auerbach, 1994; Holmes et al, 2003b; Popa et al, 2010; Richardson-Jones et al, 2010; Rossi et al, 2008a; Rossi et al, 2008b; Sinton and Fallon, 1988) . Agonists at 5-HT 1A receptors produce hypothermia in mice via a presynaptic mechanism (Li et al, 1999; Martin et al, 1992; Richardson-Jones et al, 2011) . A randomized block design was used wherein all mice received three treatments in different orders with a 3-day separation between treatmenttesting days. Mice were injected with saline or the 5-HT 1A receptor agonist 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT; 0.1 or 0.4 mg/kg, sc, calculated as the free base and dissolved in saline at 0.1 mg/ml) (Li et al, 1999; Popa et al, 2008) . Adult body weights were recorded at this time. Mice were habituated to a rectal temperature probe one day prior to the first testing day (Physitemp Instruments, Clifton, NJ). Two baseline temperatures were recorded 20 and 10 min prior to injection. Core body temperatures were recorded in 10-min increments postinjection for 1 h and then again at 90 and 120 min after injection to verify that temperatures returned to baseline.
Guide Cannula Implantation Surgery
At 10-14 months of age and following behavior testing, mice were implanted unilaterally with a guide cannula for a CMA/7 microdialysis probe (CMA/Microdialysis, Solna, Sweden) into the left ventral hippocampus in the CA3 region (coordinates relative to Bregma: AP À 2.8 mm, ML À 3.5 mm, DV À 2.2 mm) under isoflurane anesthesia. The cannula was held in place with dental resin (Bosworth Trim II, from Bosworth Company, Skokie, IL), which was secured to the skull with a stainless steel screw (Eicom-USA, San Diego, CA). Microdialysis experiments described below were performed 3-20 days after cannula implantation.
Microdialysis and No-Net-Flux Protocols
Probe insertion. At 1400-1500 hours, each subject was briefly (3-5 min) anesthetized using isoflurane for insertion of a CMA/7 microdialysis probe (active membrane length 2 mm; CMA/Microdialysis) into the guide cannula. Immediately after insertion, an aCSF solution (147 mM NaCl, 3.5 mM KCl, 1.0 mM CaCl 2 , 1.0 mM NaH 2 PO 4 , 2.5 mM NaHCO 3 , 1.2 MgCl 2 , pH 7.3 ± 0.03 at room temperature) was continuously perfused through the probe at 3 ml/min for 30-60 min followed by a 1.1 ml/min flow rate for an additional 12-14 h to allow recovery from acute injuryrelated neurotransmitter release due to probe insertion.
Microdialysis. Male and female mice treated postnatally with saline, FLX, or ESC were used in experiments to determine the effects of 8-OH-DPAT on extracellular serotonin levels. At 0330-0400 hours on the day after probe insertion, the flow rate of aCFS through the probe was increased to 3 ml/min for at least 30 min before collecting dialysate samples. Basal samples were collected in 6-min increments over the course of 2 h, after which 1.2 mM ESC was infused into the probe to increase local concentrations of extracellular serotonin (Hjorth et al, 1997; Tao et al, 2000) . Samples were collected for another 2 h. Subsequently, mice received a sc saline injection (1 ml/kg), and dialysate samples were collected for 1 h. Each mouse then received increasing doses of 8-OH-DPAT (0.025, 0.05, 0.1, 0.2, and 0.4 mg/kg, sc), and dialysate samples were collected for an additional hour after each dose. Sampling times were 6 min throughout. Dialysate samples were analyzed online continuously by high-performance liquid chromatography coupled to electrochemical detection (HTEC-500, Eicom-USA). Dialysates and standards were separated using a mobile phase composed of 96 mM NaH 2 PO 4 , 3.8 mM Na 2 HPO 4 , pH 5.4, 2.8% MeOH, 50 mg/l EDTA-Na 2 , and 500 mg/l sodium decanesulfonate in water purified by a Milli-Q Synthesis A10 system (EMD Millipore Corporation, Billerica, MA). The stationary phase was a PP-ODS II column (4.6 cm Â 3 mm, 2-mm particle size, Eicom-USA). There were no statistically significant differences between sexes, so microdialysis data from male and female mice within each postnatal treatment group were combined.
No-net-flux. Male and female mice treated postnatally with SSRIs and male SERT-deficient mice were used in experiments to determine the levels of extracellular serotonin in the ventral hippocampus. No-net-flux protocols were similar to previously published methods (Luellen et al, 2007; Mathews et al, 2004; Szapacs et al, 2004; Yang et al, 2013) with the following modifications. At 0400-0500 hours on the day following probe insertion, the flow rate of aCSF was increased to 3 ml/min at least 30 min prior to dialysate sampling. Basal samples were collected over 2 h. Subsequently, five concentrations of serotonin ranging from 2.5 to 50 nM were perfused via the microdialysis probe using a programmable gradient infusion CMA/102 pump (CMA/ Microdialysis, Harvard Apparatus, Holliston, MA). Dialysates were collected for 90 min at each concentration of serotonin. Samples were collected in 6-min intervals and analyzed online continuously as described above.
Probe verification. After microdialysis experiments, mice were killed by cervical dislocation, and the brains were rapidly removed. The anterior portion of each brain, including the hippocampus, was placed in 7% paraformaldehyde phosphate buffer (PB), pH 7.3 for 48-72 h at room temperature on a laboratory rotator. Brains were then transferred to a 30% sucrose-PB solution and stored at À 80 1C. Preserved brains were sectioned at 50 mm using a cryostat and stained by cresyl violet. Probe locations were verified under a microscope.
Autoradiography
Mice were euthanized by cervical dislocation. Brains were rapidly removed and placed on wet ice for coronal sectioning. The anterior portion was reserved for microdialysis probe placement verification as described above. Posterior portions of the brains containing the dorsal raphe nucleus (DRN) and median raphe nucleus (MRN) were placed in cold 1 Â PBS (Gibco Life Technologies, Grand Island, NY) for 1 min and then frozen on powdered dry ice. Brains were stored at À 80 1C until further processing.
A cryostat microtome (Leica CM1850, Leica Microsystems, Buffalo Grove, IL) was used to cut 20-mm coronal sections (plates 68-70) (Paxinos and Franklin, 2001 ). Brain sections were mounted on gelatin-coated slides with two sections per slide, which allowed for duplicate determinations. Sections were then desiccated for 18 h at 4 1C and maintained at À 80 1C for storage. Quantitative autoradiography for 5-HT 1A receptor binding, 5-HT 1A agoniststimulated GTP-gS binding, and SERT binding were carried out using previously published methods (Burke et al, 2013; Hensler, 2002; Licht et al, 2010; Rossi et al, 2008a) .
5-HT 1A receptor binding was assessed in the DRN and MRN using the radiolabeled antagonist [ 3 H]WAY-100635. Slide-mounted sections were thawed, desiccated at 4 1C for 1 h and preincubated (30 min, 30 1C) in assay buffer (170 mM Tris-HCl, pH 7.6). Sections were then placed in assay buffer with 2 nM [ 3 H]WAY-100635 and incubated for 60 min at room temperature. Adjacent sections were incubated in assay buffer containing [ 3 H]WAY-100635 and cold NAN190 (1 mM), to determine nonspecific binding. Sections were then washed (2 Â 5 min) in ice-cold 170 mM Tris-HCl buffer (pH 7.6), dipped in ice-cold deionized water, and dried on a slide warmer. Slides were exposed to Kodak BioMax MR film for 9 weeks. Digitized autoradiograms were analyzed using ImageJ, version 1.42q (National Institutes of Health, Bethesda, MD) (Burke et al, 2013) . Tissue sections were stained with thionin, and the brain areas were identified using a mouse brain atlas (Paxinos and Franklin, 2001 
for 60 min at 25 1C. Nonspecific binding was determined in the presence of 1 mM paroxetine. Sections were washed (2 Â 5 min) in ice-cold 50 mM Tris buffer (pH 7.4), immersed in ice-cold deionized water, and dried on a slide-warmer. Sections were exposed to Kodak Biomax MR film for 5 weeks to develop autoradiograms, which were analyzed using ImageJ, version 1.42q (National Institutes of Health).
Chemicals
S-( þ )-Citalopram oxalate and fluoxetine hydrochloride were obtained from BioTrend Chemicals (Destin, FL). ( ± )-8-Hydroxy-DPAT hydrobromide was purchased from Sigma (St Louis, MO) for administration to mice and from Tocris Bioscience (Minneapolis, Minnesota) for autoradiography. Sodium phosphate monobasic (NaH 2 PO 4 ), sodium phosphate dibasic (Na 2 HPO 4 ), NAN 190 HBr, GDP (disodium salt), and ethylenediaminetetraacetic acid disodium salt (EDTA-Na 2 ) were purchased from Sigma. Methanol was from EMD Millipore, and sodium decanesulfonate was from TCI America (Portland, OR). Sterile endotoxin-free saline was purchased from Anawa Trading (Wangen, Switzerland). GTPgS (tetralithium salt) was purchased from Roche Applied Science (Indianapolis, Indiana). WAY-100635 maleate and DPCPX were purchased from Tocris Bioscience. Paroxetine HCl was from Shanco International (Hazlet, New Jersey). 
Statistics
Periadolescent behavior data were analyzed by two-way analysis of variance (ANOVA), with sex and postnatal treatment as independent variables. Unhandled and saline-treated SERT þ / þ mice were compared using Student's unpaired t-tests. No differences between these groups occurred for any variable; therefore, data from the saline-treated and unhandled groups were combined and compared with ESC-treated mice by t-tests. Saline-treated mice were also directly compared with ESC-treated mice.
Adult behavior data were analyzed by factor analysis, which is a statistical method that reduces a large set of observed variables to a smaller number of unobserved (latent) factors to account for correlations among the observed variables (Brigman et al, 2009; Holmes and Rodgers, 1998) . Where necessary, mathematical signs were reversed, ie, reduced time/entries and head dips in the open arms reflect an increase in anxiety so the signs for these data were reversed. Prior to factor analysis, behavior data for each variable were normalized to same-sex/same-age/ treatment or genotype control groups. Standard score normalization was applied using the equation z ¼ (x À m)/ s, where x is the individual score, m is the mean for the appropriate control group, and s is the control group SD (Guilloux et al, 2011) . Saline-treated SERT þ / þ mice were controls for postnatal SSRI-treated groups. Unhandled SERT þ / þ mice were controls for genotype groups. Global behavioral phenotypes were assessed using 10 preselected, non-redundant variables by orthogonal rotation (varimax). Behavior data were used for factor analysis without removing outliers. Scree plots were used to extract factor matrices (eigenvalues 40.7). Standard scores for variables that loaded together for each factor (loadings 40.3) were combined to create an integrated score and were weighted proportionally to variable loadings. Individual group comparisons were by unpaired two-tailed t-tests according to a priori hypotheses. Prior to comparing groups, 4/41200 data points were removed as they were 4 ± 3 SDs from the group means.
Body weight, temperature, and 8-OH-DPAT microdialysis data were analyzed by two-way ANOVA, with genotype or postnatal SSRI treatment and age or dose as independent variables. With the exception of a single temperature data point that was 4 ± 3 SD from the mean, no data were removed prior to analysis. binding, the independent variables were 8-OH-DPAT concentration and postnatal antidepressant treatment. For all two-way ANOVAs, main effects were analyzed only in cases of nonsignificant interaction terms. In cases of significant interactions, data were analyzed by one-way ANOVA at each age or 8-OH-DPAT dose to determine simple effects. For no-net-flux microdialysis, data for each treatment group were regressed with perfused serotonin concentrations (C in ) on the x axis and the difference between perfused serotonin and dialysate serotonin concentrations (C in À C out ) on the y axis. Intercepts of regression lines with the x axis were used to estimate extracellular serotonin levels corrected for in vivo extraction fraction. Data were compared group-wise using a nonparametric Kruskal-Wallis test due to non-Gaussian distributions followed by Dunnett's multiple comparisons.
Statistics were computed using the GraphPad Prism v.6 (GraphPad, La Jolla, CA) or SAS Statistical Software v.9.3 (SAS Institute, Cary, NC). All data are expressed as means±SEMs, with Po0.05 considered statistically significant.
RESULTS
Adolescent Anxiety-Related Behavior After Early Postnatal ESC Exposure
Initially, we investigated the behavior in adolescent mice following developmental exposure to the commonly prescribed antidepressant ESC (Lindsley, 2012) . Anxiety-like behavior was assessed in the elevated plus maze and open field. These widely used tests measure conflict-avoidance behavior and responses to novelty in rodents. Specific aspects of these tests also enable evaluation of activity levels and exploratory behavior. Depression-related behavior was examined in the forced swim test. Mice with normal SERT expression (wild type) were treated with ESC from P5 to P21. At P50, female and male ESC-treated mice exhibited increased time and numbers of entries in the open arms of the elevated plus maze compared with saline-treated and unhandled mice indicative of reduced anxiety-related behavior (Figure 2a and b) . Anxiety-related behavior and total distance traveled in the open field and depressive-like behavior in the forced swim test were not different between periadolescent ESC-treated, saline-treated, and unhandled Postnatal Figure S1) . Late adolescent body weights at P60 were also not significantly different across groups (Supplementary Figure S2) .
Adult Behavior After Postnatal Antidepressant Exposure vs SERT Deficiency
We next investigated behavior in a large cohort of adult mice following postnatal exposure to ESC. Separate groups of mice were exposed to FLX to compare two widely prescribed SSRIs (Figure 3a ). Mice treated with saline during P5-P21 were controls for SSRI-exposed mice. To compare the effects of constitutive SERT deficiency, behavior was analyzed in untreated wild-type mice (SERT þ / þ ) and mice with complete (SERT À / À ) and partial (SERT þ / À ) loss of SERT. The latter are models of reduced SERT expression associated with low-expressing human SLC6A4 gene variants (Hu et al, 2006; Murphy and Lesch, 2008b ). Group sizes (N ¼ 13-28 mice/sex) are detailed in Supplementary Table S1 . Assessments of anxiety, depressive, locomotor, and exploratory behaviors were made beginning at 3 or 10 months of age in separate cohorts of animals (Figure 3a) . Raw data are summarized in Supplementary Table S2 .
Together, a large number of variables are associated with the elevated plus maze, open field, and forced swim (a) The timeline shows the treatment paradigm for postnatal SSRI administration and the timing of experimental testing for adult SERT-deficient and SSRI-exposed mice. For global behavior analysis, standard score normalization was applied with respect to age and sex for each variable to combine data with different dynamic ranges and directions of change (Guilloux et al, 2011) . Standard scores were weighted by coefficients proportional to their loadings in the factor analysis (Supplementary Table S3 The open field anxiety-like parameters, center time, and ratio of center to total distance traveled loaded on a separate factor ('Anxiety OFT'). (f and g) Exploration (factor 3) was determined by total arm entries and rears in the elevated plus maze and total distance traveled in the open field. Group sizes are listed in Supplementary Table S1 . *Po0.05, **Po0.01, and ***Po0.001 vs postnatal saline-treated or SERT þ / þ mice.
tests. To reduce bias in interpreting the entire data set resulting from these tests, we employed factor analysis (Brigman et al, 2009; Holmes and Rodgers, 1998) to produce unbiased global behavioral profiles (Gross et al, 2000) . Data from 10 variables collected from 4400 mice were combined for analysis. Three factors clearly emerged accounting for the majority (499%) of the common variance shared by the variables in the model (Supplementary Table S3 Tables S4-S7 ). The three factors revealed contrasting patterns of behavior between SSRI-treated mice and SERT-deficient mice and, furthermore, between mice treated postnatally with ESC vs FLX. Similar to periadolescence, in adulthood, postnatal ESC exposure was associated with reduced anxiety-related behavior in the elevated plus maze (Anxiety EPM; Po0.05; Figure 3b ). Also similar to periadolescence, adult mice exposed postnatally to ESC showed no changes in anxiety-related behavior in the open field (Anxiety OFT; Figure 3d ) or exploratory behavior (Figure 3f ). In contrast to developmental ESC exposure, adult SERT þ / À and SERT À / À mice exhibited increased anxiety-related behavior in both anxiety domains (Anxiety EPM; Po0.05; Figure 3c ; Anxiety OFT; Po0.05 SERT þ / À ; Po0.001 SERT À / À ; Figure 3e ). Exploratory behavior was reduced in SERT À / À mice (Po0.001; Figure 3g ). As adults, postnatal FLX-exposed mice were different from both postnatal ESC-exposed and SERT-deficient mice in the Anxiety EPM domain showing no change in behavior in the elevated plus maze (Figure 3b ). By contrast, mice exposed to FLX during early development showed increased anxietyrelated behavior in the open field similar to SERT-deficient mice (Po0.05; Figure 3d ). Moreover, postnatal FLX resulted in reduced exploration (Po0.01; Figure 3f ), which was also similar to SERT À / À mice.
To determine whether these behavioral effects were accompanied by altered growth, we examined weight gain during the early postnatal and adult periods ( Supplementary Figures S3 and S4) . Developmental exposure to ESC or FLX caused long-term decreases in body weight, changes that were not recapitulated in SERTdeficient mice.
Contributions of 5-HT 1A Autoreceptors
To uncover the potential mechanisms underlying divergent anxiety-related phenotypes, we investigated 5-HT 1A -autoreceptor function. Leonardo and colleagues identified presynaptic 5-HT 1A receptors as key regulators of anxietyrelated behavior, particularly during developmental time frames (Richardson-Jones et al, 2011) . Moreover, previous studies suggested divergent adaptive responses of 5-HT 1A autoreceptors to constitutive loss of SERT (Li et al, 1999) vs P5-P19 ESC administration (Popa et al, 2008) . To determine 5-HT 1A -autoreceptor responsiveness, we measured hypothermia in response to the 5-HT 1A agonist 8-OH-DPAT (Richardson-Jones et al, 2011) .
In young adult mice treated postnatally with SSRIs, lower (0.1 mg/kg) and higher (0.4 mg/kg) dose of 8-OH-DPAT significantly reduced body temperature (Supplementary Figures S5A and C and S6A and C) . Notably, mice exposed to developmental ESC showed potentiated responses to the higher dose of 8-OH-DPAT compared with saline-exposed mice (Po0.01). Both doses of 8-OH-DPAT significantly reduced body temperature in 3-month-old SERT þ / þ and SERT þ / À mice (Supplementary Figures S5B and D and S6B and D) . By contrast, SERT À / À mice showed no change in body temperature in response to either dose of 8-OH-DPAT (Po0.001). At 10 months of age, male mice treated postnatally with ESC responded to low-and highdose 8-OH-DPAT in a potentiated manner compared with saline-and FLX-treated mice (Figure 4a and c; Supplementary Table S8) . Aging female mice exposed to antidepressants showed no differences in hypothermia compared with saline-exposed mice; whereas SERT À / À mice of both sexes showed no change in body temperature after either dose of 8-OH-DPAT (Figure 4b and d and Supplementary Figure S7) .
In addition to body temperature, which is modulated by serotonergic projections to the hypothalamus, we investigated 5-HT 1A -autoreceptor-mediated suppression of extracellular serotonin levels in the ventral hippocampus, a brain region important for processing emotionally salient information. We administered 8-OH-DPAT (0.025-0.4 mg/kg) to freely moving mice and measured changes in hippocampal extracellular serotonin by microdialysis. Early-life ESC exposure was associated with potentiated extracellular serotonin responses after all doses of 8-OH-DPAT at 10 months of age (Figure 4e ; Supplementary Table S8) . Reductions in serotonin levels in ESC-exposed mice were 30% greater than those in postnatal saline-exposed mice. Only the lowest dose of 8-OH-DPAT produced a potentiated decrease in extracellular serotonin in postnatal FLXexposed mice.
Autoradiography was carried out to investigate whether changes in 5-HT 1A -autoreceptor expression and/or G-protein coupling accompanied presynaptic 5-HT 1A supersensitivity in postnatal ESC-treated mice. At 10-14 months of age, no differences in [ 
Hippocampal Serotonin Transmission
Divergent adaptation of 5-HT 1A -autoreceptor function in postnatal SSRI-treated vs SERT-deficient mice suggested underlying differences in serotonin neurotransmission. Somatodendritic 5-HT 1A receptors control serotonin release, and the sensitivity/function of these receptors is reciprocally regulated by extracellular serotonin levels . No-net-flux microdialysis was used to quantify extracellular serotonin in the ventral hippocampus in the two models of SERT disruption Yang et al, 2013) . We found significant reductions in extracellular serotonin concentrations 10-14 months after postnatal exposure to ESC compared with saline-or FLX-exposed mice (Po0.05; Figure 5a and c; Supplementary Table S8) . Conversely, SERT À / À mice showed elevated hippocampal extracellular serotonin compared with SERT þ / þ mice at this age (Po0.001; Figure 5b and d; Supplementary Table  S8) . Lesser magnitude increases in hippocampal extracellular serotonin were observed in SERT þ / À mice (Po0.05; Figure 5b and d). Mice receiving postnatal ESC also showed reduced basal dialysate serotonin levels (Po0.05), whereas SERT þ / À (Po0.01) and SERT À / À mice (Po0.001) showed increased dialysate serotonin. Dialysate serotonin levels for postnatal saline-, FLX-, and ESC-treated mice were 1.1±0.3 nM, 0.77±0.09 nM, and 0.58±0.05 nM, respectively. ]WAY-100635 in the dorsal raphe nucleus (DRN) or medial raphe nucleus (MRN) with respect to postnatal SSRI administration. For temperature and microdialysis data, N ¼ 11, 16, and 17 for postnatal saline-, FLX-, and ESC-treated mice, respectively, and N ¼ 13, 19, and 12 for SERT þ / þ , SERT þ / À , and SERT À / À mice, respectively. For autoradiography, N ¼ 3-5 mice/group. For hypothermia data, *Po0.05 and **Po0.01 vs saline-treated mice, ## Po0.01 vs FLX-treated mice, and ***Po0.001 vs SERT þ / þ mice. For microdialysis data, *Po0.05, **Po0.01, and ***Po0.001 vs postnatal saline-treated mice administered the same dose of 8-OH-DPAT.
For SERT þ / þ , SERT þ / À , and SERT À / À mice, dialysate serotonin levels were 0.58 ± 0.02 nM, 0.65 ± 0.01 nM, and 1.8 ± 0.1 nM, respectively.
We investigated whether increased SERT levels might underlie hyposerotonemia and supersensitive 5-HT 1A autoreceptors in postnatal ESC-treated mice. On the contrary, Table S8 ).
There was a trend toward decreased SERT binding in the DRN of these mice ( À 15%; Po0.08).
DISCUSSION
We conclude that early exposure to the SSRI ESC causes a protracted hyposerotonergic state associated with reduced anxiety-related behavior. In contrast, constitutive SERT deficiency is defined by a persistent hyperserotonergic state underlying heightened anxiety (Figure 1a) . Early exposure to the SSRI fluoxetine produced some but not all features associated with constitutive SERT deficiency. Altered behavior in FLX-exposed mice was not accompanied by changes in serotonergic transmission during late adulthood and thereby differed from early ESC exposure and SERT deficiency. When considered together, these findings support a role for serotonin neurotransmission in modulating adult anxietyrelated behavior. They suggest that serotonergic tone can be modified during early development by environmental and genetic factors. Moreover, anxiety-related behavior along a normal adult continuum appears to be maintained by persistent variations in serotonin transmission. Studies dating back to the early 1980s identified a critical period in rodent development where antidepressants that Intercepts (x axis) were used to estimate extracellular serotonin levels in ventral hippocampus corrected for in vivo extraction fraction. Error bars are too small to be pictured in some cases. (c and d) Extracellular serotonin was reduced in postnatal ESC-exposed mice compared with postnatal saline-exposed mice at 10-14 months of age. By contrast, extracellular serotonin was elevated in SERT þ / À and SERT À / À mice vs SERT þ / þ mice. Extracellular serotonin levels were 3.3 ± 0.6 nM, 3.8 ± 0.5 nM, and 2.2 ± 0.3 nM in saline-(N ¼ 15), FLX-(N ¼ 17), and ESC-treated (N ¼ 19) mice, respectively. Mean extracellular serotonin levels for SERT þ / þ (N ¼ 14), SERT þ / À (N ¼ 19), and SERT À / À (N ¼ 15) mice were 1.9 ± 0.4 nM, 3.2 ± 0.4 nM, and 9.0 ± 1.2 nM, respectively. (e and f) Total SERT binding was reduced in the median raphe nucleus (MRN) in postnatal ESC-treated mice (N ¼ 4-5). Representative autoradiograms are shown for each treatment group. *Po0.05 vs postnatal saline-treated mice or SERT þ / þ mice, and **Po0.01 and ***Po0.001 vs SERT þ / þ mice.
inhibit SERT were found to cause lasting changes in emotion-related behavior (Ansorge et al, 2004; Mirmiran et al, 1981; Popa et al, 2008; Vogel et al, 1990) . Only recently, however, were phenotypes associated with SERT inhibition limited to early postnatal periods (Ansorge et al, 2008; Ansorge et al, 2004; Popa et al, 2008) postulated to be similar to phenotypes manifested by SERT-deficient mice (Holmes et al, 2003b; Joeyen-Waldorf et al, 2009; Kalueff et al, 2007) . Although some aspects of these two models may resemble one another, the present findings indicate that similarities disappear when anxiety-related behavior and serotonin neurotransmission are focused on. In rodents, anxiety-like behavior is most often assessed by open arm behavior in the elevated plus maze (Walf and Frye, 2007) and activity in the center of the open field. Mice with reduced SERT expression consistently display increased anxiety-related behavior in these domains (Holmes et al, 2003a; Holmes et al, 2003b; Joeyen-Waldorf et al, 2009; Kalueff et al, 2007) . In previous reports on adult mice treated postnatally with FLX or ESC, open arm parameters were not altered (Ansorge et al, 2008; Ansorge et al, 2004; Popa et al, 2008) . These prior studies were conducted in mice on different background strains from the strain used here. Notably, SERT-deficient mice on an S129 background have high baseline anxiety that precludes geneassociated (Holmes et al, 2003a) and, possibly, postnatal SSRI exposure-associated differences in anxiety-related behavior from being detected. Additionally, elevated plus maze testing conditions vary across studies. For example, Ansorge et al (2008) tested mice during the light phase under bright light, whereas mice for the present study underwent elevated plus maze testing during the dark phase under dim lighting conditions. Similar to strain considerations, testing conditions can preclude differences in behavior from being detected. For example, the reduced anxiety-related phenotype observed here in postnatal ESCtreated mice might manifest only during higher activity dark-phase periods or be inhibited by bright lighting conditions such that modest drug-related effects are not observed.
Another finding of this study is that in mice anxietyrelated behavior in the elevated plus maze is qualitatively different from anxiety-related behavior in the open field as data from these two tests mapped onto separate factors. Using a triple-test apparatus that allows quasi-simultaneous testing in the elevated plus maze, open field test, and lightdark box, others have estimated that the overlap in anxietyrelated measures between the elevated plus maze and the open field is as low as 15% (Fraser et al, 2010) . Thus, even though both paradigms assess conflict/avoidance behavior, they are not interchangeable.
Regarding exploratory behavior, others (Ansorge et al, 2008; Ansorge et al, 2004; Karpova et al, 2009; Popa et al, 2008) and we report remarkably similar findings wherein postnatal FLX is associated with decreased exploratory behavior and increased anxiety-related behavior in the open field (but not the elevated plus maze)-changes that are similar to those occurring in SERT-deficient mice. However, SERT-deficient mice show altered 5-HT 1A -autoreceptor function and extracellular serotonin levels, whereas postnatal FLX-exposed mice do not, suggesting that it is unlikely these specific alterations in the serotonin system underlie behavioral changes in the latter. This does not preclude adaptive changes in other aspects of the serotonin system in mice with early FLX exposure, eg, serotonin receptor subtypes other than 5-HT 1A autoreceptors.
Depression-related behavior is more challenging to assess in rodent models. This behavioral domain is commonly evaluated using the forced swim test, and some have argued that in addition to predicting antidepressant efficacy, depressive-like behavior or behavioral despair can be measured by this test (Lucki, 1997) . Behavior in the forced swim test was previously evaluated in postnatal antidepressant-treated rodents, as well as rats and mice with constitutive SERT deficiency (Kalueff et al, 2006; Karpova et al, 2009; Popa et al, 2008) . Conclusions regarding similarities (or lack thereof) between these models are not clear-cut given inconsistencies in findings across studies. We did not observe differences in immobility on either of 2 consecutive days of forced swim testing (Supplementary Table S2 ), therefore we conclude that forced swim behavior is unaffected under our study conditions in both models of SERT disruption.
Reductions in 5-HT 1A binding were previously reported in DRN ( À 50%) and MRN ( À 30%) in female SERT À / À mice and in DRN ( À 30%) in male SERT À / À mice (Li et al, 2000) . Decreases in 8-OH-DPAT-stimulated [ 35 S]GTPgS binding of a similar magnitude were attributed to reduced 5-HT 1A -autoreceptor expression in this previous study. Notably, complete loss of 5-HT 1A -autoreceptor-mediated hypothermia in SERT À / À mice cannot be accounted for by these modest reductions in 5-HT 1A autoreceptors. Here potentiated 5-HT 1A -autoreceptor function in postnatal ESC-treated mice also was not explained by comparable increases in receptor binding or receptor-G-protein interactions. Together, these findings suggest that regulation at other levels, eg, plasma membrane localization (Descarries and Riad, 2012) or effector/signaling cascades, underlies adaptive differences in 5-HT 1A -autoreceptor function in SERT À / À mice and postnatal ESC-treated mice.
Increased hippocampal extracellular serotonin concomitant with desensitization and partial downregulation of 5-HT 1A autoreceptors appear to be direct responses to permanent loss of SERT, which begins during prenatal development and continues throughout life (Figure 1a) . In addition to the hippocampus, we previously reported gene-dose-dependent increases in extracellular serotonin in the striatum and frontal cortex , suggesting global effects of SERT deficiency on serotonin neurotransmission. In contrast, postnatal administration of SSRIs inhibits serotonin uptake during a limited developmental time frame. Development of the serotonin system prior to this period is unaffected in postnatal SSRI-treated mice. After the exposure period, a persistent change in hippocampal serotonin transmission takes place in mice exposed to ESC but not FLX. Early exposure to ESC might influence developmental trajectories associated with SERT expression or function (Daws et al, 2007) . Others have reported reduced SERT immunoreactivity ( À 40%) in medial prefrontal cortex and somatosensory cortex in adult rats treated postnatally with (±)citalopram (Maciag et al, 2006) . Alternately, neonatal serotonin neuronal arborization might be reduced (Maciag et al, 2006) , leading to decreased innervation of hippocampus and low extracellular serotonin and SERT levels in adult mice with postnatal ESC exposure. We observed reduced anxiety-related behavior as early as P50 in mice exposed to ESC during early postnatal development; therefore, serotonin system changes begin during or prior to adolescence.
Comparing raw data for saline-injected SERT þ / þ mice vs unhandled SERT þ / þ mice suggests increased adult body weight (Supplementary Figures S2 and S3) , hyperserotonemia ( Figure 5 ) and increased anxiety-related behavior (Supplementary Table S2 ) in the former. Thus an alternate interpretation of the study findings is that the postnatal injection paradigm is stressful to neonates. Moreover, the effects of postnatal injection stress might be reversed by postnatal ESC and, in the case of body weight, postnatal ESC or FLX. We caution that the study strategy does not support direct statistical comparisons between the two adult control groups as the study was designed to have two separate arms: drug-treatment and constitutive genetic-deficiency arms. Mice for the drug-treated arm were generated from SERT þ / þ parents that were offspring of SERT þ / À Â SERT þ / À matings. Mice for the genetic arm were generated directly from SERT þ / À Â SERT þ / À matings. This strategy enabled us to provide mice for both study arms on the same genetic background. It also avoided injecting SERT À / À mice, which are hyper-responsive to stress (Li et al, 1999; Tjurmina et al, 2002) . We do not know if genotype-related differences in maternal behavior or in utero/postnatal exposure to different genotype sibling influence body weight, serotonin transmission, or anxietyrelated behavior, which could also account for differences in the saline-injected and uninjected control groups.
Nevertheless, we investigated the potential for postnatal injection stress to influence behavior and body weight in periadolescent mice. This experiment included the salineinjected and uninjected control groups in a direct comparison design. We did not observe statistically significant behavior (Figure 2 ) or body weight (Supplementary Figure S2) differences between control groups during adolescence. Hence, we did not include unhandled control groups in the adult drug-treatment portion of the study. In the future, it may be interesting to investigate the effects of postnatal injection stress or other types of early life stressors as a function of SERT genotype. Otherwise, we are not aware of alternate means of administering drugs to early postnatal mice, eg, they are too small for minipumps, drugs administered to lactating mothers via drinking water are unlikely to achieve appropriate drug levels in nursing pups as SSRIs do not accumulate in milk to an appreciable extent (Suri et al, 2002) . We are exploring RNAi approaches and/or transient genetic knockdown strategies to avoid daily postnatal injections and potential off-target drug effects in future studies. Given the current findings, we also intend to expand upon the present behavioral comparisons using a broader array of tests.
Notably, with the exception of reduced adult body weights in male mice, the two SSRIs studied here produced dissimilar outcomes. Postnatal ESC exposure was predominantly associated with persistent reductions in anxietyrelated behavior in the elevated plus maze and hyposerotonemia, whereas lasting increases in anxiety-like behavior specific to the open field and decreases in exploratory behavior were cardinal features of postnatal FLX exposure.
Although all SSRIs share the ability to inhibit SERT with high affinity, each SSRI differs in chemical structure and therefore is capable of interacting uniquely with other biological targets, most of which are unknown. Differences in adult behavior and physiology following postnatal exposure to specific antidepressants may be due to differences in allosteric interactions with SERT or off-target effects (Carrasco and Sandner, 2005; Zhong et al, 2012) . Furthermore, FLX but not citalopram requires norepinephrine to manifest antidepressant behavioral effects (Cryan et al, 2004) , thus adult outcomes associated with early developmental FLX but not ESC exposure may involve changes in noradrenergic system function. Moreover, while the doses of FLX and ESC administered here have been shown to produce serum drug levels at P21 in the human therapeutic range, the half-lives of FLX and ESC differ, and it has been suggested that P5-P21 dosing with ESC may not produce the steady-state drug levels similar to postnatal FLX dosing (Ansorge et al, 2008; Popa et al, 2008) . Consequently, pharmacokinetic effects could contribute to adult differences between postnatal ESC-and FLX-exposed mice.
One additional point that merits consideration is that adult body weight reductions mostly specific to male mice (Supplementary Figure S4) were similar for ESC vs FLX exposure even though behavioral changes associated with these two drugs were different and present in male and female mice. In light of the latter, we suspect that long-term behavioral consequences of early life SSRI exposure are not strongly tied to decreased body weight. However, we cannot separate potential interactions between altered growth in male mice following early exposure to SSRIs from long-term behavioral consequence.
Further work will be needed to uncover the reasons for the differences in the developmental effects of ESC vs FLX and to extend the current findings to other SSRIs commonly used to treat depression and anxiety during pregnancy. Importantly, antidepressant responses to different SSRIs vary in patients. The effects of antidepressant treatment during pregnancy on human offspring are controversial (Oberlander et al, 2009) . Nonetheless, outcomes associated with antidepressant therapy need to be weighed against those associated with foregoing treatment for major depressive and anxiety disorders as untreated maternal depression and anxiety have recognized effects on developmental and neurobehavioral outcomes in children (Brand and Brennan, 2009) .
Human serotonin transmission likely spans a continuum of states ranging from low to high serotonergic tone (Murphy et al, 2008a; Oberlander et al, 2009) . Current antidepressant therapies are ineffective in treating anxiety and depression in a large numbers of patients, and advances in predicting individual responses are hindered by difficulties associated with characterizing complex influences of genetic and environmental factors on serotonergic transmission in humans. Highly controlled animal models, such as those studied here, represent avenues by which to identify factors potentially influencing behavioral domains associated with emotion-related disorders. To translate information from animal models, we developed methods to assess clinically relevant serotonin uptake in human peripheral blood cells (Beikmann et al, 2013; Leuchter et al, 2010) , which could enable personalized medicine strategies targeting pharmacotherapies with different mechanisms to patients suffering from depression and/or anxiety disorders based on SERT functional status. In the future, these methods could also be used to investigate the effects of early SSRI exposure and SLC6A4 gene variants on adult human serotonergic phenotypes.
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